Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 8, 2026

Molecular and Antiangiogenic Effects of Paclitaxel-Loaded Nanoparticles: Influence of the Nanocarrier Type.

View Full Paper
Ask AI
Bookmark
Share

Authors

JPJulia Sapienza PassosGMGiovanna Barros de MeloGSGiovanna Cassone Salata

Discussion

Loading...

Member takes

Overview

Demonstrates how nanoparticle type influences drug effectiveness and safety in breast cancer, suggesting improved treatment approaches.

Key Points

  • The aim is to investigate the effects of different nanoparticle types on the efficacy and biological activity of paclitaxel in breast cancer cells.
  • Developed nanostructured lipid carriers (NLCs) and lipid-polymeric hybrid nanoparticles (H-NPs) for paclitaxel delivery.
  • Assessed apoptosis and DNA damage in breast cancer cell lines, including MCF-7 and MDA-MB-231.
  • Examined antiangiogenic effects in the chicken chorioallantoic membrane model.
  • NLC-PTX induced greater α-tubulin acetylation and DNA damage compared to H-NP-PTX.
  • Paclitaxel as a solution caused lesser effects than the nanoencapsulated forms in terms of cytotoxicity.
  • Nanoencapsulation lowered irritation while maintaining significant antiangiogenic activity, achieving 6.1-7.8-fold vessel growth inhibition.

Cite This Study

Passos et al. (2026) studied this question.

synapsesocial.com/papers/69ada885bc08abd80d5bb807https://doi.org/10.1021/acs.molpharmaceut.5c01740
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Minimizing Cytotoxic Effects on Normal Cells: Enhanced Targeted Delivery of Docetaxel via PCL-PEG-PCL Nanocarriers in Breast Cancer Treatment2025
  2. 2Synthesis and Characterization of Paclitaxel-Loaded Silver Nanoparticles: Evaluation of Cytotoxic Effects and Antimicrobial Activity2024 · 20 citations
  3. 3Chitosan Nanoparticles of Paclitaxel for the Treatment against MDA-MB-231 Breast Cancer Cells via Oral Nanomedicine: Fabrication and Preclinical Assessment2026
  4. 4Paclitaxel-loaded nanostructured lipid carriers surface-functionalized with N6L for pancreatic cancer.2026
  5. 5The Current Landscape of Nanopaclitaxel Formulations and the Benefits of Polymeric Micellar Paclitaxel in Solid Tumors2026 · 1 citations